Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.4 EUR | -0.22% | +4.15% | +10.49% |
11:22am | EVONIK : Berenberg gives a Neutral rating | ZD |
10:28am | EVONIK : Deutsche Bank maintains a Buy rating | ZD |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.84 for the current period. Therefore, the company is undervalued.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company is one of the best yield companies with high dividend expectations.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company does not generate enough profits, which is an alarming weak point.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.49% | 10.24B | A | ||
+17.40% | 66.6B | A- | ||
+0.84% | 48.75B | A- | ||
+17.11% | 41.45B | B+ | ||
+22.26% | 26.74B | A- | ||
+11.45% | 19.55B | C+ | ||
+5.03% | 18.21B | B+ | ||
-21.31% | 16.02B | A- | ||
+4.18% | 15.62B | B+ | ||
-8.51% | 15.33B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- EVK Stock
- Ratings Evonik Industries AG